Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Chalcones are a class of natural products with diverse biological activities.
• The development of novel anticancer agents is a critical area of research.
• Structure-activity relationships of chalcones are being explored for therapeutic potential.

Purpose of the Study:

• To synthesize and evaluate a series of 2',5'-dihydroxychalcones for their cytotoxic effects.
• To identify chalcone derivatives with potent and selective anticancer activity.
• To investigate the anti-angiogenic and in vivo anti-tumor effects of promising compounds.

Main Methods:

• Synthesis of 2',5'-dihydroxychalcone analogs with varying substituents on the B ring.
• In vitro cytotoxicity assays against various human tumor cell lines and human umbilical venous endothelial cells (HUVEC).
• In vitro HUVEC tube formation assay and in vivo anti-tumor efficacy study in BDF1 mice bearing Lewis lung carcinoma.

Main Results:

• Chalcones with electron-withdrawing substituents on the B ring displayed potent cytotoxicity against tumor cell lines.
• Compounds with extended or heteroaromatic rings showed significant bioactivity.
• 2-chloro-2',5'-dihydroxychalcone (2-3) exhibited high cytotoxic selectivity (index up to 66) against HCT116 cells and inhibited HUVEC tube formation.
• Compound 2-3 demonstrated a 60.5% inhibition of tumor growth in a mouse model.

Conclusions:

• 2',5'-dihydroxychalcones represent a promising scaffold for anticancer drug development.
• Substitution patterns on the B ring significantly influence cytotoxic potency and selectivity.
• 2-chloro-2',5'-dihydroxychalcone shows potential as an anti-angiogenic and anti-tumor agent.